GT Biopharma, Inc.

📍 Brisbane, United States🗓 Founded 1973👥 7 employees💰 Last funded 2020
Biotechnology Research🌐 gtbiopharma.com
Website LinkedIn
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary NK cell engager (TriKE) platform technology. (NASDAQ: GTBP)
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1973
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in GT Biopharma, Inc.?
GT Biopharma, Inc. has 1 investors on record on gritt.io.
When did GT Biopharma, Inc. last raise funding?
The most recent investment in GT Biopharma, Inc. recorded on gritt.io was in 2020.
When was GT Biopharma, Inc. founded?
GT Biopharma, Inc. was founded in 1973.
What industry is GT Biopharma, Inc. in?
GT Biopharma, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GT Biopharma, Inc. based?
GT Biopharma, Inc. is headquartered in Brisbane, United States.